Related Experiment Video
Updated: Jan 21, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer
Qiong Lou1,2, Ruixian Liu1, Xiangling Yang1
1Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, Guangdong, China.
Background:
Indoleamine 2,3-dioxygenase 1 (IDO1) is a critical regulator of T cell function, contributing to immune tolerance. Upregulation of IDO1 has been found in many cancer types; however, the regulatory mechanisms and clinical significance of IDO1 in colon cancer are still unclear. Here, we investigated the role of dysregulated microRNA (miRNA) targeting IDO1 in the colon cancer microenvironment.
Methods:
We elucidated IDO1 function by performing cell-based assays and establishing transplanted tumor models in BALB/c mice and BALB/c nude mice. We evaluated IDO1 protein expression by immunohistochemistry (IHC) in a tissue microarray (TMA) and analyzed IDO1 mRNA expression with The Cancer Genome Atlas (TCGA). We screened miRNAs targeting IDO1 by using a dual luciferase reporter assay. We tested the function of microRNA-448 (miR-448) by using western blotting (WB) and fluorescence-activated cell sorting (FACS).
Results:
We demonstrated that stable IDO1 overexpression enhanced xenograft tumor growth in BALB/c mice but not in BALB/c nude mice. We also revealed the involvement of posttranscriptional regulation of IDO1 in colon cancer by observing IDO1 protein levels and mRNA levels. Furthermore, ectopic expression of miRNA mimics suggested that miR-448 could significantly downregulate IDO1 protein expression. Notably, we proved that miR-448 suppressed the apoptosis of CD8+ T cells by suppressing IDO1 enzyme function.
Conclusion:
Our findings indicated that IDO1 suppressed the CD8+ T cell response in colon cancer. miR-448, as a tumor-suppressive miRNA, enhanced the CD8+ T cell response by inhibiting IDO1 expression. The results provide a theoretical basis for the development of new immunotherapy for the treatment of colon cancer.
Insights
Indoleamine 2,3-dioxygenase 1 (IDO1) suppresses CD8+ T cell responses in colon cancer. MicroRNA-448 (miR-448) enhances these responses by inhibiting IDO1, offering a basis for novel colon cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Indoleamine 2,3-dioxygenase 1 (IDO1) regulates T cell function and immune tolerance.
- IDO1 is upregulated in various cancers, but its role in colon cancer remains unclear.
- Investigating microRNA (miRNA) regulation of IDO1 in the colon cancer microenvironment is crucial.
Purpose of the Study:
- To elucidate the function and regulation of IDO1 in colon cancer.
- To identify specific miRNAs targeting IDO1 in the colon cancer microenvironment.
- To determine the therapeutic potential of targeting the IDO1-miRNA axis for colon cancer immunotherapy.
Main Methods:
- Utilized cell-based assays and transplanted tumor models in mice.
- Assessed IDO1 expression via immunohistochemistry (IHC) and The Cancer Genome Atlas (TCGA).
- Screened targeting miRNAs using dual luciferase reporter assays and validated miR-448 function via western blotting (WB) and fluorescence-activated cell sorting (FACS).
Main Results:
- IDO1 overexpression promoted tumor growth in immunocompetent mice.
- MicroRNA-448 (miR-448) significantly downregulated IDO1 protein expression.
- miR-448 suppressed CD8+ T cell apoptosis by inhibiting IDO1 activity.
Conclusions:
- IDO1 inhibits the CD8+ T cell response in colon cancer.
- miR-448 acts as a tumor suppressor by enhancing the CD8+ T cell response via IDO1 inhibition.
- These findings support the development of IDO1-targeting immunotherapies for colon cancer.
Related Concept Videos
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Regulation of the Unfolded Protein Response
Targeted Cancer Therapies
There are several types of targeted therapies against...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Colonization of Land
Master Transcription Regulators

